LAURA SUHAN: Open Payments
NPI 1053866319 · NORTH BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,096 in 47 payments from 16 companies in 2025. Trend: 2023 $701 · 2024 $610 · 2025 $1,096
Food & beverage: $1,096
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $262 |
| Neurocrine BioSciences, Inc. | 3 | $170 |
| SK Life Science, Inc. | 7 | $138 |
| Grifols USA, LLC | 2 | $119 |
| ARGENX US, INC. | 5 | $86 |
| AstraZeneca Pharmaceuticals LP | 1 | $70 |
| ABBVIE INC. | 3 | $48 |
| Aucta Pharmaceuticals, Inc. | 4 | $38 |
| Neurelis, Inc. | 2 | $33 |
| Otter Pharmaceuticals, LLC | 2 | $30 |
Products named: INGREZZA, Briviact, Gamunex-C, VYVGART HYTRULO, WAINUA, Fintepla, Motpoly XR, Biomet SpinalPak Non-invasive Spine Fusion Stimulator System.
Industry payments across NJ — which companies pay providers there.
